10x Genomics, Inc.
Nasdaq · Laboratory Analytical Instruments
Company Overview
A concise company profile alongside the latest public filing activity.
10x Genomics develops and sells instruments, consumables, and software for single-cell and spatial genomics analysis, allowing researchers to study gene expression and biological processes at the level of individual cells within tissues.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| STUELPNAGEL JOHN RInsider | Sell | $425K | 7,012at $60.66 | Sep 3, 2026 |
| STUELPNAGEL JOHN RInsider | Sell | $423K | 6,814at $62.11 | Sep 3, 2026 |
| STUELPNAGEL JOHN RInsider | Sell | $387K | 6,174at $62.61 | Sep 3, 2026 |
| Saxonov SergeChief Executive Officer | Sell | $415K | 6,494at $63.98 | Aug 26, 2026 |
| Saxonov SergeChief Executive Officer | Sell | $221K | 3,500at $63.02 | Aug 26, 2026 |
| Saxonov SergeChief Executive Officer | Sell | $32K | 492at $64.75 | Aug 26, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable TXG activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.